News - Chemence Medical, Inc.

Jan

Chemence Medical Received FDA Approval for exofin Precision Pen

stacey | January 31, 2022

January 31, 2022 Chemence Medical, Inc., a manufacturer and distributor of adhesive-based medical devices, announced it received Food and Drug Administration clearance to market and sell the Exofin® Precision Pen as a new medical device for wound closure. The Exofin Precision Pen will enable medical providers greater versatility and exactness in closing wounds while also … Chemence Medical Received FDA Approval for exofin Precision Pen

May

Chemence Opens New Research and Development Facility

ben | May 5, 2021

Chemence Center of Excellence to focus on adhesive technology innovation Alpharetta, GA — Chemence, a global company with specialized expertise in the field of polymerizable technology, announced the opening of the Chemence Center of Excellence, a state-of-the-art research and development facility in Alpharetta, Georgia. The facility is home to a large team of Chemence’s scientists … Chemence Opens New Research and Development Facility

Exofin Fusion Skin Closure System Image of mesh strip and adhesive applicator tube.

Apr

Chemence Medical Receives FDA Approval for Exofin Fusion® Redesign

ben | April 9, 2021

Medical technologies manufacturer improves patient care with enhanced skin closure system Alpharetta, GA — Chemence Medical, a world leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion® skin closure system. Exofin fusion combines a self-adhering flexible mesh strip and a fast-curing 2-octyl … Chemence Medical Receives FDA Approval for Exofin Fusion® Redesign

Feb

Chemence Medical Receives FDA Clearance for Exofin® Tissue Adhesive

ben | February 25, 2016

Alpharetta, Georgia – February 15, 2016 Chemence Medical, Inc., a manufacturer and distributor of adhesive-based medical devices, announced it received Food and Drug Administration clearance to market and sell Exofin®, a new topical skin adhesive for wound closure. Exofin enters the market as the fastest polymerizing 2-octyl cyanoacrylate topical adhesive available and as the highest … Chemence Medical Receives FDA Clearance for Exofin® Tissue Adhesive

Latest News - Chemence Medical, Inc.

Chemence Medical Received FDA Approval for exofin Precision Pen

Chemence Opens New Research and Development Facility

Chemence Medical Receives FDA Approval for Exofin Fusion® Redesign

Chemence Medical Receives FDA Clearance for Exofin® Tissue Adhesive